RAE1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.058800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.346000E-01
Normal-vs-Stage2
8.863400E-01
Normal-vs-Stage3
1.955250E-01
Normal-vs-Stage4
5.260000E-01
Stage1-vs-Stage2
8.355200E-01
Stage1-vs-Stage3
1.141370E-01
Stage1-vs-Stage4
8.010800E-01
Stage2-vs-Stage3
9.736100E-02
Stage2-vs-Stage4
7.636400E-01
Stage3-vs-Stage4
2.095800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.361600E-01
Normal-vs-AfricanAmerican
7.058200E-01
Normal-vs-Asian
5.350000E-01
Caucasian-vs-AfricanAmerican
8.273400E-01
Caucasian-vs-Asian
3.623000E-01
AfricanAmerican-vs-Asian
8.197400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.663200E-01
Normal-vs-Female
7.289400E-01
Male-vs-Female
1.578210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.317000E-01
Normal-vs-Age(41-60Yrs)
7.223200E-01
Normal-vs-Age(61-80Yrs)
6.502600E-01
Normal-vs-Age(81-100Yrs)
9.602800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.465600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.341600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.305000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.595900E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.506400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.399600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.026400E-01
Normal-vs-Daily Drinker
9.536200E-01
Normal-vs-Weekly Drinker
9.807200E-01
Normal-vs-Occasional Drinker
4.913400E-01
Normal-vs-Social Drinker
7.401000E-01
Non Drinker-vs-Daily Drinker
6.990300E-02
Non Drinker-vs-Weekly Drinker
4.046400E-01
Non Drinker-vs-Occasional Drinker
9.898100E-03
Non Drinker-vs-Social Drinker
4.784400E-01
Daily Drinker-vs-Weekly Drinker
9.079800E-01
Daily Drinker-vs-Occasional Drinker
1.456970E-01
Daily Drinker-vs-Social Drinker
4.519200E-01
Weekly Drinker-vs-Occasional Drinker
2.742400E-01
Weekly Drinker-vs-Social Drinker
7.105400E-01
Occasional Drinker-vs-Social Drinker
7.813700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.653200E-01
Normal-vs-Grade 2
7.579400E-01
Normal-vs-Grade 3
7.826000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.185200E-01
Grade 1-vs-Grade 3
6.082600E-01
Grade 1-vs-Grade 4
7.653200E-01
Grade 2-vs-Grade 3
2.692800E-01
Grade 2-vs-Grade 4
7.579400E-01
Grade 3-vs-Grade 4
7.826000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.456200E-01
Normal-vs-NonDiabetic
9.284000E-01
Diabetic-vs-NonDiabetic
1.209920E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.637800E-01
Normal-vs-NoPancreatitis
9.541600E-01
Pancreatitis-vs-NoPancreatitis
5.083000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.891200E-01
Normal-vs-N1
9.034200E-01
N0-vs-N1
9.573400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.110600E-01
Normal-vs-TP53-NonMutant
9.404800E-01
TP53-Mutant-vs-TP53-NonMutant
9.478500E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
